Holocene Advisors, LP

Position in MLTX — MoonLake Immunotherapeutics

CIK 1700574 New York, NY

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,867,500

-$6,316,500 QoQ

Shares Held

250,000

-58.3% QoQ

Ownership

0.294%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#42

of 172 holders

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Holocene Advisors, LP holds $1,266,200,483 across 29 Biotechnology names. MLTX ranks #18 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	1,359,269	$254,563,898
2	DNLI	Denali Therapeutics Inc.	3,905,225	$100,442,387
3	CYTK	Cytokinetics Inc	1,144,579	$97,506,685
4	SRRK	Scholar Rock Holding Corp	1,755,978	$96,578,790
5	ARWR	Arrowhead Pharmaceuticals, Inc.	1,106,177	$90,164,487
6	SYRE	Spyre Therapeutics, Inc.	1,015,170	$90,126,792
7	MDGL	Madrigal Pharmaceuticals, Inc.	152,924	$82,112,541
8	TNGX	Tango Therapeutics, Inc.	2,410,939	$75,365,953

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,867,500	250,000	-58.3%	Shares	Sole	2026-08-14
2026-03-31	$11,184,000	600,000	+217.5%	Shares	Sole	2026-05-15
2025-03-31	$7,383,800	188,989	-88.1%	Shares	Sole	2025-05-15
2024-12-31	$85,836,793	1,585,167	0.0%	Shares	Sole	2025-02-14
2024-09-30	$79,924,120	1,585,167	-2.5%	Shares	Sole	2024-11-14
2024-06-30	$71,510,213	1,626,341	+11.8%	Shares	Sole	2024-08-14
2024-03-31	$73,078,069	1,454,869	+51.3%	Shares	Sole	2024-05-15
2023-12-31	$58,054,718	961,330	+808.4%	Shares	Sole	2024-02-14
2023-09-30	$6,031,854	105,822	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.